Shiraz Transplant Center, Abu Ali Sina Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Science, Shiraz, Iran.
J Surg Res. 2022 Aug;276:168-173. doi: 10.1016/j.jss.2022.02.047. Epub 2022 Mar 25.
Peritoneal adhesion formation is a challenging postoperative complication. We aim to evaluate the effect of orally administered sirolimus, prednisolone, and their combination to prevent this entity.
Eighty female albino underwent intraperitoneal injection of 3 mL of 10% sterile talc solution to induce peritoneal adhesion, and were subsequently and randomly divided into four groups (each n = 20); including a control group; 1 mg/kg oral prednisolone daily in the morning; 0.1 mg/kg oral sirolimus daily; and a combination group which received both drugs, with the same dosage. On the 29th day, abdominal cavities were explored, and classification was done based on Nair classification.
All rats were healthy on the 29th day, in which exploration was performed. The rats in the control group had extensive intra-abdominal adhesions, while 17 (85%) rats in the control group had substantial adhesion; however, the prednisolone, sirolimus, and combination group had lesser adhesion formation. Also, 14 (70%) rats of prednisolone group, 13 (65%) of sirolimus group, and 16 (80%) of combination group had insubstantial adhesion. The decrease in the grade of peritoneal adhesion bands was highly significant in the combination group (P > 0.001).
The combination of sirolimus and prednisolone was effective for preventing peritoneal adhesions in rats.
腹膜粘连形成是一种具有挑战性的术后并发症。我们旨在评估口服西罗莫司、泼尼松龙及其联合应用预防这种并发症的效果。
80 只雌性白化大鼠腹膜内注射 3ml 10%无菌滑石粉溶液,以诱导腹膜粘连,然后随机分为四组(每组 n=20):对照组;每天早上口服 1mg/kg 泼尼松龙;每天口服 0.1mg/kg 西罗莫司;以及联合组,给予相同剂量的两种药物。第 29 天,探查腹腔,并根据 Nair 分类进行分类。
所有大鼠在第 29 天均健康,进行了探查。对照组的大鼠有广泛的腹腔内粘连,而对照组的 17 只(85%)大鼠有大量的粘连;然而,泼尼松龙、西罗莫司和联合组的粘连形成较少。泼尼松龙组 14 只(70%)、西罗莫司组 13 只(65%)和联合组 16 只(80%)的大鼠粘连程度较轻。联合组腹膜粘连带分级的降低具有高度显著性(P>0.001)。
西罗莫司和泼尼松龙联合应用对预防大鼠腹膜粘连有效。